Survival Outcome of Alternative Medicine Treatment for Newly Diagnosed Acute Leukemia in Children

被引:5
|
作者
Chotsampancharoen, Thirachit [1 ]
Sripornsawan, Pornpun [1 ]
Duangchu, Sarapee [1 ]
Wongchanchailert, Malai [1 ]
McNeil, Edward [2 ]
机构
[1] Prince Songkla Univ, Fac Med, Dept Pediat, Hat Yai 90110, Thailand
[2] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Thailand
关键词
Childhood leukemia; Alternative medicine; Survival outcomes; BREAST-CANCER; UNITED-STATES; COMPLEMENTARY; THERAPIES; PERCEPTIONS; PREVALENCE; THAILAND; REMEDIES;
D O I
10.1159/000493417
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is scarce information on the efficacy of alternative medicine (AM) alone as a treatment for newly diagnosed acute leukemia in children. We aimed to compare overall survival (OS) between children with newly diagnosed acute leukemia who received AM alone as the first-line treatment and those treated with conventional chemotherapy (CCT). Methods: Two-to-one nearest-neighbor propensity score-matching using sex, initial white blood cell count, phenotype of leukemia, and period of diagnosis was performed on 184 patients who received CCT and 92 who received AM alone after being diagnosed with leukemia. A multivariable Cox proportional-hazards regression model was then applied to assess the effect of treatment on OS after adjusting for potential confounders. Hazard ratios (HR) and 95% confidence intervals (CI) are provided. Results: After adjusting for initial white cell count and subtype of leukemia, children treated with AM alone had worse OS (HR 5.14, 95% CI 3.75-7.04) than those given CCT. The 5-year OS rate for newly diagnosed acute leukemia treated with AM medicine alone was 0%. Conclusion: AM without CCT is associated with poorer survival when compared with CCT. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:203 / 208
页数:6
相关论文
共 50 条
  • [1] PROGNOSTIC FACTORS AND TREATMENT OUTCOME OF CHILDREN WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA.
    Zahra, K.
    Ben Sayed, N.
    Ben Youssef, Y.
    Zaier, M.
    Achour, B.
    Rgaieg, H.
    Khelif, A.
    HAEMATOLOGICA, 2014, 99 : 571 - 571
  • [2] Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis
    Inaba, Hiroto
    Fan, Ying
    Pounds, Stanley
    Geiger, Terrence L.
    Rubnitz, Jeffrey E.
    Ribeiro, Raul C.
    Pui, Ching-Hon
    Razzouk, Bassem I.
    CANCER, 2008, 113 (03) : 522 - 529
  • [3] Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia
    Reville, Patrick K.
    Kadia, Tapan
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (04)
  • [4] Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia
    Patrick K. Reville
    Tapan Kadia
    Current Treatment Options in Oncology, 2020, 21
  • [5] Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
    Karp, Judith E.
    Lancet, Jeffrey E.
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (03): : 491 - 500
  • [6] Effect of arsenic trioxide on the treatment of children with newly diagnosed acute promyelocytic leukemia in China
    Li Zhang
    Xiaofan Zhu
    Yao Zou
    Yumei Chen
    Xiaojuan Chen
    International Journal of Hematology, 2011, 93 : 199 - 205
  • [7] Effect of arsenic trioxide on the treatment of children with newly diagnosed acute promyelocytic leukemia in China
    Zhang, Li
    Zhu, Xiaofan
    Zou, Yao
    Chen, Yumei
    Chen, Xiaojuan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (02) : 199 - 205
  • [8] Markers of hypercoagulability in children with newly diagnosed acute lymphoblastic leukemia
    Carmona, Roxana
    Kizilocak, Hande
    Marquez-Casas, Elizabeth
    Vasquez, Siobhan
    Ji, Lingyun
    Ko, Richard H.
    Young, Guy
    Jaffray, Julie
    PEDIATRIC BLOOD & CANCER, 2022, 69 (03)
  • [9] Bone Histomorphometry in Children with Newly Diagnosed Acute Lymphoblastic Leukemia
    Jan A Leeuw
    Jan Koudstaal
    Janneke Wiersema-Buist
    Willem A Kamps
    Wim Timens
    Pediatric Research, 2003, 54 : 814 - 818
  • [10] Bone histomorphometry in children with newly diagnosed acute lymphoblastic leukemia
    Leeuw, JA
    Koudstaal, J
    Wiersema-Buist, J
    Kamps, WA
    Timens, W
    PEDIATRIC RESEARCH, 2003, 54 (06) : 814 - 818